Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Maraganore John
Relationship:   Director
City:   Cambridge
State:   MA
   
Insider Summary:
  
   
Companies Owned :   4    
Direct Shares   263,534    

Indirect Shares

   6,153,633      
Direct Value   $34,888,515    

Indirect Value

   $14,549,676      
Total Shares   6,417,167      
Total Value   $49,438,191      


Alnylam Pharmaceuticals Inc $33,792,019 Agios Pharmaceuticals Inc $1,091,218 Bluebird Bio, Inc. $5,279 Alnylam Pharmaceuticals Inc $33,792,019 Agios Pharmaceuticals Inc $1,091,218 Bluebird Bio, Inc. $5,279
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Alnylam Pharmaceuticals Inc ALNY Chief Executive Office... 2021-12-22 227,663 2021-12-22 3,133    Premium*  
            Regulus Therapeutics Inc. RGLS Director, 10% Owner 2012-10-10 0 2012-10-10 6,150,500    Premium*  
            Agios Pharmaceuticals Inc AGIO Director 2022-05-20 30,028 0    Premium*  
            Bluebird Bio, Inc. BLUE Director 2017-09-14 5,843 2014-07-14 0    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
RGLS Regulus Therapeutics Inc. Director   –       •       •   2012-10-10 4 A $0.00 $0 I/I 6,150,500 6,150,500 0 -
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2018-11-21 4 OE $21.35 $2,105,879 D/D 98,636 249,933 0 -
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2017-11-15 4 AS $125.54 $9,387,951 D/D (74,000) 149,710 0 -
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2017-11-15 4 OE $31.39 $2,322,860 D/D 74,000 223,710 0 -
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2017-11-22 4 AS $129.97 $9,609,736 D/D (73,415) 149,710 0 -
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2017-11-22 4 OE $31.39 $2,304,497 D/D 73,415 223,125 0 -
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2015-11-20 4 OE $7.10 $845,017 D/D 69,254 192,079 0 -
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2013-07-10 4 AS $37.11 $2,226,822 D/D (60,000) 18,617 0 -
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2013-07-10 4 OE $0.95 $57,000 D/D 60,000 78,617 0 -
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2013-08-14 4 AS $48.77 $2,938,127 D/D (60,000) 18,617 0 -
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2013-08-14 4 OE $0.95 $57,000 D/D 60,000 78,617 0 -
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2018-11-21 4 D $72.68 $4,356,439 D/D (59,940) 189,993 0 -
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2013-09-11 4 OE $0.95 $56,000 D/D 58,947 77,564 0 -
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2013-09-11 4 AS $55.41 $3,271,524 D/D (58,947) 18,617 0 -
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2015-11-20 4 AS $102.34 $6,037,933 D/D (58,690) 133,389 0 -
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2015-12-02 4 AS $103.15 $6,154,715 D/D (58,689) 133,389 0 -
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2015-12-02 4 OE $13.12 $770,000 D/D 58,689 192,078 0 -
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2014-05-14 4 AS $57.20 $3,259,715 D/D (56,834) 106,320 0 -
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2014-05-14 4 OE $6.78 $385,335 D/D 56,834 163,154 0 -
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2014-05-15 4 OE $6.78 $400,973 D/D 56,834 163,154 0 -
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2014-05-15 4 AS $56.06 $3,188,227 D/D (56,834) 106,320 0 -
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2014-06-25 4 OE $7.47 $424,550 D/D 56,834 163,154 0 -
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2014-06-25 4 AS $65.86 $3,757,171 D/D (56,834) 106,320 0 -
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2014-06-26 4 OE $7.47 $424,550 D/D 56,834 163,154 0 -
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2014-06-26 4 AS $64.66 $3,682,926 D/D (56,834) 106,320 0 -
  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us